A Study to Evaluate the Pharmacokinetic Drug-drug Interactions Between VX-548, Midazolam, and Digoxin
Completed · Phase 1
Conditions studied: Pain
In brief
The purpose of this study is to evaluate the pharmacokinetics of midazolam and digoxin in the absence and presence of VX-548.
Key facts
- Study ID
- NCT05541471
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 37
- Starts
- 2022-09-22
- Expected to finish
- 2023-04-28
- Last updated by the study team
- 2024-03-20
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Baltimore - Early Phase Clinical Unit — Baltimore, Maryland, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.